Molecular Templates, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Marketable Securities and Fair Value Measurements (Tables)

Marketable Securities and Fair Value Measurements (Tables)

3 Months Ended

Mar. 31, 2018

Financial Assets at Fair Value on Recurring Basis

The following table sets forth the Company’s financial assets (cash equivalents and marketable securities) at fair value on a recurring basis as of March 31, 2018 and December 31, 2017 (in thousands):

			Basis of Fair Value Measurements
	Fair Value as of March 31, 2018		Level 1		Level 2		Level 3
Money market funds	$	48,830	$	48,830	$	—	$	—

			Basis of Fair Value Measurements
	Fair Value as of December 31, 2017		Level 1		Level 2		Level 3
Money market funds	$	51,751	$	51,751	$	—	$	—

Summary of Company's Available-for-Sale Securities

The Company invests in highly-liquid, investment-grade securities. The following is a summary of the Company’s available-for-sale securities at March 31, 2018 and December 31, 2017 (in thousands):

As of March 31, 2018	Cost Basis			Unrealized Gain		Unrealized Loss		Fair Value
Money market funds	$	48,830		$	—	$	—	$	48,830
Less cash equivalents		(48,830	)		—		—		(48,830	)
Total marketable securities	$	—		$	—	$	—	$	—

As of December 31, 2017 (in thousands):	Cost Basis			Unrealized Gain		Unrealized Loss		Fair Value
Money market funds	$	51,751		$	—	$	—	$	51,751
Less cash equivalents		(51,751	)		—		—		(51,751	)
Total marketable securities	$	—		$	—	$	—	$	—

Financial Liabilities at Fair Value on Recurring Basis

The following is table sets forth the Company’s financial liabilities measured at fair value on a recurring basis as of the date indicated below:

			Basis of Fair Value Measurements
	Fair Value as of March 31, 2018		Level 1		Level 2		Level 3
2017 Warrants		340		—		—		340

			Basis of Fair Value Measurements
	Fair Value as of December 31, 2017		Level 1		Level 2		Level 3
2017 Warrants		954		—		—		954

- Definition

Tabular disclosure of available-for-sale securities which includes, but is not limited to, changes in the cost basis and fair value, fair value and gross unrealized gain (loss), fair values by type of security, contractual maturity and classification, amortized cost basis, contracts to acquire securities to be accounted for as available-for-sale, debt maturities, transfers to trading, change in net unrealized holding gain (loss) net of tax, continuous unrealized loss position fair value, aggregate losses qualitative disclosures, other than temporary impairment (OTTI) losses or other disclosures related to available for sale securities.

+ References + Details